INTERNATIONAL PATENT: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS FILES APPLICATION FOR "THERANOSTIC PSMA-TARGETING LIGANDS FOR THE DIAGNOSIS AND TREATMENT OF PSMA-EXPRESSING CANCERS AND THEIR SOLID PHASE SYNTHESIS"

GENEVA, May 5 -- DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (Im Neuenheimer Feld 28069120 Heidelberg) filed a patent application (PCT/EP2024/080276) for "THERANOSTIC PSMA-TARGETING LIGANDS FOR THE DIAGNOSIS AND TREATMENT OF PSMA-EXPRESSING CANCERS AND THEIR SOLID PHASE SYNTHESIS" on Oct 25, 2024. With publication no. WO/2025/088147, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SCHAFER, Martin (Am Stangenberg 969239 Neckarsteinach), BAUDER-WUEST, Ulrike (Im Klingen 769198 Schriesheim), ROSCHER, Ma...